Status not kept up to date
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System
NCT06054867 · PROCEPT BioRobotics · Updated 14 Aug 2024
- What is being tested
- Robotic Waterjet Treatment
- For
- Localized Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 40 years and older. About 22 people. The full rules are on the registry page.
- Where
- United States (3 sites)
- When
- Starts or started 11 March 2024, ends April 2025. Registered 26 Sept 2023.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Sites
- University of Southern California, Institute of UrologyLos Angeles, California, United States
- NorthShore University HealthSystemGlenview, Illinois, United States
- NYU Grossman School of MedicineNew York, New York, United States